Autoimmune premature ovarian failure
- PMID: 28250725
- PMCID: PMC5327623
- DOI: 10.5114/pm.2016.65666
Autoimmune premature ovarian failure
Abstract
Premature ovarian failure (POF), also termed as primary ovarian insufficiency (POI), is a highly heterogenous condition affecting 0.5-3.0% of women in childbearing age. These young women comprise quite a formidable group with unique physical and psychological needs that require special attention. Premature ovarian senescence (POS) in all of its forms evolves insidiously as a basically asymptomatic process, leading to complete loss of ovarian function, and POI/POF diagnoses are currently made at relatively late stages. Well-known and well-documented risk factors exist, and the presence or suspicion of autoimmune disorder should be regarded as an important one. Premature ovarian failure is to some degree predictable in its occurrence and should be considered while encountering young women with loss of menstrual regularity, especially when there is a concomitant dysfunction in the immune system.
Keywords: adrenal insufficiency; anti-ovarian antibodies; autoimmune disorders; premature ovarian failure; primary ovarian insufficiency.
References
-
- Santoro N. Mechanisms of premature ovarian failure. Ann Endocrinol (Paris) 2003;64:87–92. - PubMed
-
- Nelson LM, Bakalov VK. Mechanisms of follicular dysfunction in 46,XX spontaneous premature ovarian failure. Endocrinol Metab Clin North Am. 2003;32:613–637. - PubMed
-
- Hoek A, Schoemaker J, Drexhage HA. Premature ovarian failure and ovarian autoimmunity. Endocr Rev. 1997;18:107–134. - PubMed
-
- Silva CA, Yamakami LY, Aikawa NE, et al. Autoimmune primary ovarian insufficiency. Autoimmun Rev. 2014;13:427–430. - PubMed
-
- Vujovic S, Brincat M, Erel T, et al. EMAS position statement: Managing women with premature ovarian failure. Maturitas. 2010;67:91–93. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources